Prelude Capital Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,000
| Closed | -$44.8K | – | 1171 |
|
|
2024
Q4 | $44.8K | Buy |
+25,000
| New | +$44.8K | ﹤0.01% | 1020 |
|
|
2022
Q2 | – | Sell |
-20,350
| Closed | -$126K | – | 1630 |
|
|
2022
Q1 | $126K | Hold |
20,350
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q4 | $289K | Sell |
20,350
-1
| -0% | -$14 | 0.01% | 1049 |
|
|
2021
Q3 | $163K | Buy |
+20,351
| New | +$163K | ﹤0.01% | 1069 |
|
|
2021
Q1 | – | Sell |
-23,304
| Closed | -$278K | – | 1187 |
|
|
2020
Q4 | $278K | Buy |
23,304
+10,804
| +86% | +$129K | 0.01% | 542 |
|
|
2020
Q3 | $86K | Buy |
+12,500
| New | +$86K | ﹤0.01% | 729 |
|